Mechanistically, we identified that, in sepsis, the Akt/mTOR/SREBP2 signaling pathway is augmented in naive CD4+ T cells, promoting cholesterol metabolism and facilitating Treg differentiation and functionality. The gene discussed is SREBF2; the disease is Sepsis.